The elevated SIRT1 then stabilizes the hypoxia-inducible factor 1 α (HIF1α) protein through deacetylation, which subsequently promotes glycolytic metabolism and contributes to the chemoresistance observed in pancreatic cancer cells. The gene discussed is HIF1A; the disease is pancreatic neoplasm.